Sympathetic nervous system influence on the innate immune response

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 195-207

  Maestroni, Georges J M ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Adaptive immunity; Adrenergic receptors; Autoimmune diseases; CD25+; CD4+; Dendritic cells; Epidermal keratinocytes; Innate immunity; Regulatory T cells; Sympathetic nervous system; T cell priming; Toll like receptors

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 10; INTERLEUKIN 12; NORADRENALIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR;

ADRENERGIC SYSTEM; ANTIBODY SPECIFICITY; AUTOIMMUNITY; BONE MARROW; CELL FUNCTION; CELL MIGRATION; CONFERENCE PAPER; CONTACT SENSITIZATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; EPIDERMIS; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; KERATINOCYTE; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION; SKIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TH1 CELL; TH2 CELL;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 33745616075     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.017     Document Type: Conference Paper

References (42)

1. MAESTRONI, G.J.M. 2000. Dendritic cells migration controlled by α1b-adrenergic receptors. J. Immunol. 165: 6743-6747.
2. MAESTRONI, G.J.M. 2002. Short exposure of antigen-stimulated dendritic cells to norepinephrine: impact on kinetic of cytokine production and Th polarization. J. Neuroimmunol. 129: 106-114.
3. MAESTRONI, G.J.M. 2004. Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and Th priming. J. Invest. Dermatol. 122: 119-124.
4. STEINKRAUS, V. et al. 1993. Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin. Arch. Dermatol. Res. 285: 300-304.
5. HALEVY, S. & E. LIVNI. 1993. Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism. J. Am. Acad. Dermatol. 29: 504-505.
6. SCHALLREUTER, K.U. 1997. Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. J. Investig. Dermatol. Symp. Proc. 2: 37-40.
7. KUPPER, T.S. & R.C. FUHLBRIGGE. 2004. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4: 211-222.
8. SHORTMAN, K. & C. CAUX. 1997. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 15: 409-419.
9. SALLGALLER, M.L. & P.A. LODGE. 1998. Use of cellular and cytokine adjuvants in the immunotherapy of cancer. J. Surg. Oncol. 68: 122-138.
10. WEINLICH, G. et al. 1998. Entry into lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J. Invest. Dermatol. 110: 441-448.
11. BANCHERAU, J. & R.M. STEINMAN. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
12. SCHNARE, M. et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
13. KALINSKI, P. et al. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20: 561-567.
14. PULENDRAN, B., K. PALUCKA & J. BANCHEREAU. 2001. Sensing pathogens and tuning immune responses. Science 293: 253-256.
15. MAESTRONI, G.J. 2000. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 165: 6743-6747.
16. MAESTRONI, G.J. & P. MAZZOLA. 2003. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J. Neuroimmunol. 144: 91-99.
17. MAESTRONI, G.J. 2002. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J. Neuroimmunol. 129: 106-114.
18. SEIFFERT, C. et al. 2002. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J. Immunol. 168: 6128-6135.
19. STRAUB, R.H. et al. 2000. A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-alpha and IL-6 secretion in the spleen. FASEB J. 14: 1380-1388.
20. RICE, P.A. et al. 2001. Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J. Neuroimmunol. 114: 19-27.
21. MIURA, K. et al. 2001. Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection. Infect. Immun. 69: 7234-7241.
22. MISRA, N. et al. 2004. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172: 4676-4680.
23. COLANTONIO, L. et al. 2002. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur. J. Immunol. 32: 3506-3514.
24. PASARE, C. & R. MEDZHITOV. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
25. SALOMON, B. et al. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
26. Wu, A.J. et al. 2002. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99: 12287-12292.
27. MEDZHITOV, R. 2001. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1: 135-145.
28. TAKEDA, K., T. KAISHO & S. AKIRA. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
29. KUPPER, T.S. & R.W. GROVES. 1995. The interleukin-1 axis and cutaneous inflammation. J. Invest. Dermatol. 105: 62S-66S.
30. GRONE, A. 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88: 1-12.
31. SCHALLREUTER, K.U. et al. 1995. Catecholamines in human keratinocyte differentiation. J. Invest. Dermatol. 104: 953-957.
32. CHEN, J., B.B. HOFFMAN & R.R. ISSEROFF. 2002. Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate - independent mechanism. J. Invest. Dermatol. 119: 1261-1268.
33. PULLAR, C.E., J. CHEN & R.R. ISSEROFF. 2003. PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J. Biol. Chem. 278: 22555-22562.
34. YILMAZ, M.B. et al. 2002. Beta-blocker-induced psoriasis: a rare side effect - a case report. Angiology 53: 737-739.
35. BAKER, B.S. et al. 2003. Normal keratinocytes express toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br. J. Dermatol. 148: 670-679.
36. MEMPEL, M. et al. 2003. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol. 121: 1389-1396.
37. KRUEGER, J.G. & A. BOWCOCK. 2005. Psoriasis pathophysiology: current concepts of pathogenesis. Ann. Rheum. Dis. 64: ii30-ii36.
38. MITTERMANN, I. et al. 2004. Autoimmunity and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 4: 367-371.
39. OU, L.S. et al. 2004. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy Clin. Immunol. 113: 756-763.
40. GRACA, L. et al. 2004. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells. Proc. Natl. Acad. Sci. USA 101: 10122-10126.
41. SAINT-MEZARD, P. et al. 2004. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur. J. Dermatol. 14: 131-138.
42. MCELWEE, K.J. et al. 2003. Alopecia areata susceptibility in rodent models. J. Investig. Dermatol. Symp. Proc. 8: 182-187.